Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
READ-THROUGH INDUCING AGENT AND PHARMACEUTICAL APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/186365
Kind Code:
A1
Abstract:
The present invention relates to a novel read-through inducing agent, and also relates to a compound represented by general formula (I) (symbols in the formula are as described in the specification) or a pharmaceutically accepted salt thereof, and a pharmaceutical composition containing the compound as an effective component. Because the compound has the read-through activity, the present invention can provide a drug useful as an agent to prevent or treat nonsense-mediated genetic diseases such as muscular dystrophy, Duchenne muscular dystrophy, cystic fibrosis, mucopolysaccharidosis, ceroid lipofuscinosis, and Niemann-Pick disease.

Inventors:
TAKEDA SHIGEMITSU (JP)
SHIRAHASE HIROAKI (JP)
TAKASHIMA SHUNSUKE (JP)
KITAO TATSUYA (JP)
Application Number:
PCT/JP2018/014162
Publication Date:
October 11, 2018
Filing Date:
April 02, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KYOTO PHARMA IND (JP)
International Classes:
C07D215/12; A61K31/352; A61K31/415; A61K31/4174; A61K31/4192; A61K31/4196; A61K31/42; A61K31/421; A61K31/426; A61K31/437; A61K31/4439; A61K31/47; A61K31/495; A61K31/4965; A61K31/498; A61K31/4985; A61K31/501; A61K31/505; A61K31/506; A61K31/517; A61K31/5377; A61P21/00; A61P43/00; C07D215/233; C07D231/12; C07D233/64; C07D239/74; C07D241/12; C07D241/42; C07D249/06; C07D249/08; C07D261/12; C07D263/32; C07D263/34; C07D263/57; C07D271/06; C07D271/10; C07D277/28; C07D295/135; C07D311/30; C07D401/04; C07D403/06; C07D413/04; C07D471/04
Domestic Patent References:
WO2012061260A12012-05-10
WO2014020350A12014-02-06
WO2014020351A12014-02-06
WO2002057216A12002-07-25
WO1998004508A11998-02-05
WO2018026811A22018-02-08
WO2017167183A12017-10-05
Foreign References:
JP2016508998A2016-03-24
JP2015527340A2015-09-17
JP2012500216A2012-01-05
JP2009531370A2009-09-03
JP2007514772A2007-06-07
JP2002528417A2002-09-03
JP2002526495A2002-08-20
US20170020846A12017-01-26
JP2002069057A2002-03-08
Other References:
SALUNKE, B. SANTOSH ET AL.: "Design and synthesis of novel an ti-tuberculosis agents from the celecoxib pharmacophore", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 23, no. 9, 1 May 2015 (2015-05-01), pages 1935 - 1943, XP055558253, Retrieved from the Internet
CHIU, HAO-CHIEH ET AL.: "Development of novel antibacterial a gents against methicillin-resistant Staphylococcus aureus", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 20, no. 15, 1 August 2012 (2012-08-01), pages 4653 - 4660, XP028428222
SUN, XICHENG ET AL.: "Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: Carboxa mide modification", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, no. 6, 15 March 2012 (2012-03-15), pages 2338 - 2342, XP028402869, Retrieved from the Internet
PARRISH A. CYNTHIA ET AL.: "Novel ATP-Competitive Kinesin Spindle Protein Inhibitors", JOURNAL OF MEDICINAL CHEMISTRY, vol. 50, no. 20, 4 October 2007 (2007-10-04), pages 4939 - 4952, XP055558263, Retrieved from the Internet
TANAKA, RIEKO ET AL.: "Design and synthesis of piperidine far nesyltransferase inhibitors with reduced glucuronidation pot entail", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 15, no. 3, 2007, pages 1363 - 1382, XP055558268
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: